In an interview with Amy Spallone, MD, from The University of Texas MD Anderson Cancer Center, the study investigates the effects of COVID-19 precautions on healthcare-associated infections, revealing surprising results in central line-associated bloodstream infections (CLABSIs), C difficile infections, and more.
International Infection Prevention and Control Week highlights the importance of preventing infections in health care and other settings. Share this poem to help educate others about IPC.
Building Information Modeling (BIM) plays a pivotal role in designing health care facilities that minimize infection risks, promoting efficient planning, and coordination while reducing construction challenges.
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA, and SHEA Chair, highlights IDWeek 2023's hybrid format and discusses the critical topic of antimicrobial resistance, emphasizing the role of vaccines in reducing AMR.
At IDWeek 2023, a look into managing VAIs in children.
An immunocompromised keynote speaker, Kevin Kavanagh, MD, shares strategies for safe air travel during the COVID-19 pandemic, emphasizing mask usage, vaccinations, and air quality monitoring, with mixed observations throughout the journey.
A study of 28 nursing homes and nearly 29,000 residents reveals that universal decolonization significantly lowered infection-related hospitalizations, offering hope for improved healthcare outcomes.
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending October 15, 2023.
A study in Maryland from June 2019 to December 2021 analyzed 140 Candida auris cases, revealing that patients often resided in disadvantaged neighborhoods with higher crowding, uninsured rates, and racial diversity. ICT speaks to the lead author.
A phase 3 trial presented at IDWeek 2023 shows that sulbactam-durlobactam (SUL-DUR) reduces mortality and improves outcomes in hospital-acquired Acinetobacter baumannii-calcoaceticus complex infections compared to colistin, offering a promising treatment option.
Meriwether County School District prioritizes student safety by implementing CASPR Technology, enhancing air and surface disinfection for a healthier learning environment.
Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Dr. Isaac Kohane explores AI's rapid medical evolution and the challenges of accuracy, updating, and education in infectious diseases at IDWeek 2023.
BiomX Develops BX004-A, a Phage Therapy, for Cystic Fibrosis Patients with Pseudomonas Infections. A phase 1b/2a study presents promising results at IDWeek 2023.
Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level. This makes it an objective tool to inform public response to common seasonal illnesses.
This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.
FDA approved emergency use of Novavax COVID-19 vaccine (NVX-CoV2601) for ages 12 years and older. It also protects against current variants.
In the delicate world of neonatal care, every precaution is taken to protect premature infants in the Neonatal Intensive Care Unit (NICU). It's crucial to acknowledge the strides made in safeguarding these vulnerable infants, whose wellbeing hinges on the meticulous efforts of health care professionals and evolving best practices.
Heating, ventilation, and air conditioning (HVAC) systems are vital for maintaining air quality in health care facilities. They play a crucial role in reducing disease transmission by regulating air quality. Proper HVAC systems decrease risk through ventilation, filtration, and airflow control.
Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.
Deborah Birx, MD, highlights concerns about the lack of data-driven action in the fight against COVID-19. She emphasizes the need for timely alerts and empowering communities to protect vulnerable individuals.
Doe Kley, MPH, RN, T-CHEST, LTC-CIP, CIC, speaks to Infection Control Today about her presentation and other exceptional presentations at the Association for the Health Care Environment (AHE) Exchange Conference & Solution Center
The AHE Exchange Conference in Dallas focused on emerging pathogens and the role of environmental services. Doe Kley, MPH, RN, T-CHEST, LTC-CIP, CIC, discusses hers and other exceptional presentations with Infection Control Today.
Ambassador Deborah Birx, MD, discusses whether students should be required to wear masks to protect themselves and others and what the public should know about the newest COVID-19 variant, B.A.2.86.
Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.
In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.
Plague doctors' historical attire was an early form of PPE. While modern PPE has improved, the quest for better, more comfortable protection continues as we aim for a future where health care workers can provide care confidently.
Health care environmental professionals met in Dallas, Texas, from July 31 to August 2, 2023, at the AHE Exchange Conference & Solution Center. Infection Control Today® asked Rock Jensen, AHE advisory board chair and administrative director of support services for Yuma Regional Medical Center in Arizona, about AHE’s areas of emphasis for leadership in environmental services (EVS).
Besides its influenza pipeline, mRNA technology is helping this pharmaceutical company create a number of new vaccines for cancer, rare diseases, and infectious diseases.
Hepatitis C cases increased in 2021, while A and B decreased. The pandemic may have impacted the progress.
